WNT3A and glioblastoma: Treatment with rh‐WNT3A enhanced invasion of GBM and induced mesenchymal markers (Figure 3I and Figure S5G, Supporting Information); however, an effect on tumor growth was not observed (n = 4 per group) (Figure S5H–K, Supporting Information).